Back to Journals » Journal of Inflammation Research » Volume 19
Cardiomyocyte Stim1 Deficiency Exacerbates Doxorubicin Cardiotoxicity by Magnification of Endoplasmic Reticulum Stress [Retraction]
This retraction applies to:
published online on 14/08/2021Zhu J, Zhang X, Xie H, Wang Y, Zhang X, Lin Z. J Inflamm Res. 2021;14: 3945–3958. https://doi.org/10.2147/JIR.S304520
We, the Editor and Publisher of Journal of Inflammation Research have retracted the published article.
After publication, concerns were raised by a third party in 2023 regarding the integrity of Figures 4 and 7 of the article.
Further investigation conducted by the Journal and Publisher identified significant integrity concerns in Figures 1, 4, 5, 6 and 7 of the article due to unexpected similarities with multiple previous publications from unrelated author groups.
When approached for an explanation, the authors did not respond to the queries raised by the Journal and Publisher. As verifying the validity of published work is core to the integrity of the scholarly record, we are therefore, retracting the article. The corresponding author has been informed.
We have been informed in our decision-making by our editorial policies and the COPE guidelines. The retracted articles will remain online to maintain the scholarly record, but they will be digitally watermarked on each page as ‘Retracted’.
This retraction relates to this paper
© 2026 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.